According to our market capitalization data, Krystal Biotech (KRYS) reached a market cap of $3.64 billion, securing the top spot among global Gene therapy companies. CRISPR Therapeutics (CRSP) and Beam Therapeutics (BEAM) follow closely behind. The data was last updated on June 01, 2025.
Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
---|---|---|---|---|---|---|
1
|
![]() Krystal Biotech
KRYS
|
$3.64 B | $125.96 |
-22.4%
|
-23.3%
|
![]() United States
|
2
|
![]() CRISPR Therapeutics
CRSP
|
$3.13 B | $36.29 |
-3.5%
|
-36.5%
|
![]() Switzerland
|
3
|
![]() Beam Therapeutics
BEAM
|
$1.59 B | $15.83 |
-20.1%
|
-35.1%
|
![]() United States
|
4
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B | $9.50 |
0.00%
|
210.5%
|
![]() United States
|
5
|
![]() uniQure
QURE
|
$0.79 B | $14.47 |
-8.9%
|
171.5%
|
![]() Netherlands
|
6
|
![]() Intellia Therapeutics
NTLA
|
$0.71 B | $6.87 |
-18.6%
|
-70.8%
|
![]() United States
|
7
|
![]() Taysha Gene Therapies
TSHA
|
$0.58 B | $2.71 |
10.2%
|
-25.1%
|
![]() United States
|
8
|
![]() MeiraGTx
MGTX
|
$0.41 B | $5.12 |
-20.6%
|
3.6%
|
![]() United States
|
9
|
![]() Verve Therapeutics
VERV
|
$0.40 B | $4.45 |
-13.8%
|
-15.2%
|
![]() United States
|
10
|
![]() Benitec Biopharma
BNTC
|
$0.39 B | $15.36 |
6.4%
|
109.0%
|
![]() United States
|
11
|
![]() Neurogene
NGNE
|
$0.24 B | $17.01 |
12.6%
|
-54.3%
|
![]() United States
|
12
|
![]() enGene
ENGN
|
$0.20 B | $3.84 |
4.3%
|
-52.0%
|
![]() Canada
|
13
|
![]() Prime Medicine
PRME
|
$0.15 B | $1.18 |
-24.8%
|
-82.0%
|
![]() United States
|
14
|
![]() Cellectis S.A.
ALCLS.PA
|
$0.15 B | $1.51 |
-8.8%
|
-44.8%
|
![]() France
|
15
|
![]() Voyager Therapeutics
VYGR
|
$0.15 B | $2.74 |
-21.5%
|
-68.3%
|
![]() United States
|
16
|
![]() Editas Medicine
EDIT
|
$0.14 B | $1.72 |
11.7%
|
-68.2%
|
![]() United States
|
17
|
![]() Sangamo Therapeutics
SGMO
|
$0.11 B | $0.47 |
-34.7%
|
-19.0%
|
![]() United States
|
18
|
![]() Korro Bio
KRRO
|
$0.11 B | $11.42 |
-35.4%
|
-77.4%
|
![]() United States
|
19
|
![]() bluebird bio
BLUE
|
$48.67 M | $4.97 |
25.2%
|
-74.1%
|
![]() United States
|
20
|
![]() Adverum Biotechnologies
ADVM
|
$46.38 M | $2.22 |
-38.2%
|
-71.4%
|
![]() United States
|
21
|
![]() Passage Bio
PASG
|
$27.12 M | $0.44 |
21.8%
|
-64.8%
|
![]() United States
|
22
|
![]() Generation Bio
GBIO
|
$25.35 M | $0.38 |
-7.6%
|
-87.6%
|
![]() United States
|
23
|
![]() AVROBIO
AVRO
|
$5.24 M | $1.40 |
0.00%
|
-100.0%
|
![]() United States
|